Clinical experience with filler complications

Dermatologic Surgery

Volumn 35, Issue SUPPL. 2, 2009, Pages 1661-1666

  Cox, Sue Ellen ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Aesthetic Solutions   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; FILLER; HYALURONIC ACID; HYALURONIDASE; HYDROQUINONE; POLYLACTIC ACID; STEROID;

ADULT; AGED; ALLERGIC REACTION; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; ERYTHEMA; EXPERIENCE; FEMALE; HUMAN; HYPERPIGMENTATION; PATIENT SAFETY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCAR; SUBCUTANEOUS NODULE; SUN EXPOSURE; SWELLING; WOUND CARE;

ACNE KELOID; ADULT; AGED; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; ECCHYMOSIS; ERYTHEMA; FACE; FEMALE; FOREIGN-BODY REACTION; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; LACTIC ACID; MIDDLE AGED; POLYMERS; REJUVENATION; SKIN AGING; TREATMENT OUTCOME;

EID: 70350549917     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01345.x     Document Type: Article

References (9)

1. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008 34 (Suppl 1) : S92 9.
2. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004 114 : 277.
3. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004 5 : 82 7.
4. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 2003 17 : 2471 2477.
5. ® (polylactic acid) in the treatment of HIV-associated lipoatrophy of the face (HALF). Paper presented at: XIV International AIDS Conference 2002; July 7-12, 2002; Barcelona, Spain.
6. Mest DR, Humble G. Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antivir Ther 2004 9 : L36.
7. Mertz PM Cutaneous biofilms: friend or foe? Wounds 2003 15 : 129 132.
8. Narins RS, Jewell M, Rubin M, et al. Clinical Conference: Management of rare events following dermal fillers-focal necrosis and angry red bumps. Dermatol Surg 2006 32 : 426 434.
9. Hirsch RJ, Cohen JL, Carruthers J. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007 33 : 357 360.